Abstract:71 Background: Colorectal cancer (CRC) remains a major health burden worldwide. Screening is employed due to its proven efficacy in reducing CRC incidence and mortality. In Uruguay, there is a longstanding National CRC screening program using fecal occult blood test (FOBT) as the preferred method. It is to be expected that patients with screen-detected CRC have better prognosis than those with symptoms due to earlier diagnosis and other favorable tumor/host characteristics. Beyond the well described earlier stage at diagnosis, other aspects have not been widely studied and data is sparse. An increasing proportion of CRC patients are diagnosed by screening rather than symptoms. Aim: We sought to establish and evaluate the correlation between clinicopathological features and TNM stage at diagnosis and diagnostic modality. Methods: A retrospective review of all newly diagnosed CRC patients from January 2008 to December 2021 was conducted by the authors. A total of 934 patients aged 50-80 years at diagnosis were included. Clinical, histological, diagnostic and treatment data was collected and findings were stratified and correlated according to screening detection vs symptomatic patients. Results: On one hand, 15% of patients had a positive FOBT leading up to their diagnosis. FOBT detected tumors presented a less advanced locoregional T-N staging (p = 0.001). Tumors were preferentially located in the proximal colon (33.1 vs 19.9%); p<0.001. Stage I CRC was more frequently detected in subjects with positive FOBT (14.2%) than in individuals with symptoms (5.9%); p = 0.002. Conversely, detection rates for stage IV CRC were 17.7% and 26.7% respectively; p = 0.002. A higher percentage of stage III screened patients underwent adjuvant chemotherapy when compared to their symptomatic counterparts (97.7 vs. 85.0 %, p = 0.016). On the other hand, 793 patients (85 %) were diagnosed after onset of signs or symptoms. There was a preponderance of advanced-stage disease (stages III–IV 36-27% respectively). The most common symptoms reported were change in bowel habits (52%), abdominal pain (47 %) and bleeding (45%). The most common overall sign was anemia. One hundred eighty-two patients (22.5%) required an emergency surgery mainly for obstructive colon cancer. Conclusions: Despite equal access to colorectal cancer screening, in Uruguay diagnosis after development of symptomatic cancer remains more common. FOBT detected cancers presented less advanced clinicopathological characteristics and differing management that potentially could be driving a more favorable outcome. Mode of detection is therefore an important indicator that should be taken into account when defining risk assessment in treatment decisions. These findings also support the need for continued improvement and recruitment of patients into screening programs. It must be the focus for future initiatives.

[Cost-effectiveness of screening for colorectal cancer in Argentina]

Quality improvement intervention to increase colorectal cancer screening at the primary care setting: a cluster-randomised controlled trial

[Cost-Effectiveness Analysis on Colorectal Cancer Screening Program].

Cost-effectiveness of colorectal cancer screening programmes using sigmoidoscopy and immunochemical faecal occult blood test

Preparation and properties of clamoxyquin pamoate, an antiamebic and antidiarrheal agent.

Cost-effectiveness analysis of colorectal cancer screening in a low incidence country: The case of Saudi Arabia

Amphetamine Increases Phosphorylation of Extracellular Signal-regulated Kinase and Transcription Factors in the Rat Striatum via Group I Metabotropic Glutamate Receptors

Cost-effectiveness analysis of colonoscopy and fecal immunochemical testing for colorectal cancer screening in China

Improved beam confinement in the modified betatron with strong focusing.

Yield and Effectiveness of 2-Sample Fecal Immunochemical Test-Based Screening Program for Colorectal Cancer.

Population-based organized screening by faecal immunochemical testing and colorectal cancer mortality: a natural experiment

The comparative cost-effectiveness of colorectal cancer screening using faecal immunochemical test vs. colonoscopy

A committee solution of the pattern recognition problem (Corresp.)

Cost-Effectiveness of Current Colorectal Cancer Screening Tests

Optimising colorectal cancer screening acceptance: a review

Feasibility and Colonoscopy Yield using the Fecal Immunochemical Test (FIT)-based Colorectal Screening in a Latin America Country

Cost-effectiveness analysis of alternative colorectal cancer screening strategies in high-risk individuals

[Anti-Ki/PA28gamma antibody].

Optimising colorectal cancer screening in Shanghai, China: a modelling study

Barriers to the use of tests for early detection of colorectal cancer in Chile

Screening or symptoms? Colorectal cancer diagnosis in Uruguay.